✦ LIBER ✦

Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors

✍ Scribed by Carlomagno, Francesca; Guida, Teresa; Anaganti, Suresh; Vecchio, Giancarlo; Fusco, Alfredo; Ryan, Anderson J; Billaud, Marc; Santoro, Massimo

Book ID: 110068880
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 350 KB
Volume: 23
Category: Article
ISSN: 0950-9232
DOI: 10.1038/sj.onc.1207810

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The multiple endocrine neoplasia type 2

The multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease are due to different mutations in the receptor tyrosine kinase ret

✍ Bruce Ponder; Lois Mulligan; Charis Eng; Patrick Edery; Stanislas Lyonnet; Darri 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Multiple BCR-ABL kinase domain mutations

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

✍ Neil P. Shah; John M. Nicoll; Bhushan Nagar; Mercedes E. Gorre; Ronald L. Paquet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB

The BCR–ABL1 T315I mutation and addition

The BCR–ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy

✍ Malcikova, Jitka; Razga, Filip; Jurcek, Tomas; Dvorakova, Dana; Zackova, Daniela 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 244 KB